Product Program year 2024 Source: CMS Open Payments

Riptide

Device Stents

PDI 00847536029118

Open in the dashboard

General payments

$21,201

41 payments

Research payments

$0

0 payments

Through program year 2024, $21,201 in general payments and $0 in research payments were reported against Riptide (Stents).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $10,857 18
2023 General $395 10
2022 General $9,613 10
2021 General $336 3

Breakdown

Who paid General payments · program years 2021–2024
  1. Medtronic, Inc. $21,201 41 payments
Top recipients General payments · program year 2024
  1. Melhem Ghaleb Vascular & Interventional Radiology · El Paso, TX $3,727 34% · 6 payments
  2. David Stewart Interventional Cardiology · Chicago, IL $3,408 31% · 7 payments
  3. Christopher Stampe Vascular & Interventional Radiology · Plymouth, MN $2,925 27% · 1 payment
  4. Osmanuddin Ahmed Diagnostic Radiology · Chicago, IL $750 7% · 1 payment
  5. Aaron Berez Neuroradiology · Mountain View, CA $17 <1% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Vascular & Interventional Radiology Radiology $6,652 61% · 2 practitioners
  2. Interventional Cardiology Internal Medicine $3,408 31% · 1 practitioner
  3. Diagnostic Radiology Radiology $750 7% · 1 practitioner
  4. Neurological Surgery $31 <1% · 2 practitioners
  5. Neuroradiology Radiology $17 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Indiana $3,408 31% · 1 recipient
  2. Texas $2,930 27% · 1 recipient
  3. Minnesota $2,925 27% · 1 recipient
  4. New Mexico $798 7% · 1 recipient
  5. Illinois $750 7% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

41 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record